Show simple item record
dc.description.abstractIn December 2019 a novel coronavirus (2019-nCoV) was identified as the causative agent of a severe acute respiratory illness among people exposed in a seafood market in Wuhan, China. Human-to-human transmission has been documented, including in healthcare workers, and aerosol-generating procedures (AGP)† may play a role in the spread of the disease. There are uncertainties in the natural history of the 2019-nCoV, including source(s), transmissibility mechanisms, viral shedding, and persistence of the virus in the environment and on fomites. As of 6 February 2020, the following precautions are recommended for the care of patients with suspected or confirmed cases of 2019-nCoV: For any suspected or confirmed cases of 2019-nCoV: standard + contact + droplet precautions; for any suspected or confirmed cases of 2019-nCoV and AGP: standard + contact + airborne precautions. The use of personal protective equipment (PPE) by healthcare workers requires an evaluation of the risk related to healthcare-related activities. These recommendations are preliminary and subject to review as new evidence becomes available.en_US
dc.subjectCommunicable Diseasesen_US
dc.subjectPersonal Protective Equipmenten_US
dc.subjectSARS Virusen_US
dc.subjectMiddle East Respiratory Syndrome Coronavirusen_US
dc.subjectSevere Acute Respiratory Syndromeen_US
dc.subjectLaboratory Personnelen_US
dc.subjectTechnical Specificationsen_US
dc.titleRequirements and technical specifications of personal protective equipment (PPE) for the novel coronavirus (2019-ncov) in healthcare settingsen_US
dc.typeProcedures, manuals, guidelinesen_US
dc.rights.holderPan American Health Organizationen_US
dc.contributor.corporatenamePan American Health Organizationen_US
paho.publisher.countryUnited Statesen_US
paho.publisher.cityWashington, D.C.en_US
paho.contributor.departmentHealth Emergencies (PHE)en_US

Files in this item


This item appears in the following Collection(s)

Show simple item record